I'm so sorry for your loss. What a terrible and traumatic experience.
With the evidence provided from historical trials and more recently, I'd like to think if ever there was a strong potential treatment to give some AML patients back their lives, Zantrene would be it. Time will tell...
Mindless Pondering:
I often wonder how much interaction small companies like RACE have with the patients in their trials. Perhaps answered in other threads, but could you imagine the tears in the eyes of all standing in the room hearing the news that the trial drugs have succeeded where all other treatments have failed? There wouldn't be a dry eye in the room. Would be interesting to know what type of feedback loop makes its way to Dr T and the team.
Ann: First Patient Dosed in Phase 1b/2 AML Trial, page-65
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
0.055(3.59%) |
Mkt cap ! $270.1M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.60 | $1.53 | $79.91K | 51.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 23239 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |